MedTrace Logo

Appropriate Limit Value for 1 mg DST in Patients With Chronic Renal Failure

NCT05568602 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1034

Last updated 2022-10-05

No results posted yet for this study

Summary

In this study, we aimed to determine a specific cut-off value for 1mg DST to prevent false positivity usually seen in CRF patients according to the standard cut-off value of 1.8 mcg/dl.

Conditions

  • Cushing Syndrome

Interventions

DIAGNOSTIC_TEST

Dexamethasone suppression test

1 mg Dexamethasone overnight suppression test for screening of hypercortisolism

Sponsors & Collaborators

  • Marmara University

    lead OTHER

Principal Investigators

  • Özlem ÜSTAY · Marmara University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2021-06-01
Completion
2021-08-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05568602 on ClinicalTrials.gov